BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Drug Development

  COVID-19-Related Stroke Risk and Omicron-Specific Vaccine May Not be Necessary

  COVID-19 is a respiratory illness and presents many other symptoms, including blood clots. For more details and other COVID-19 news, continue reading.

  February 7, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  P2X3 Receptor Antagonist Field Murkier as Bayer Abandons Program

  After reviewing available data, Bayer decided to abandon its Phase II development of eliapixant as the benefit-risk profile was not worthwhile.

  February 7, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Medable, CVS Forge Alliance to Improve Clinical Trial Access

  To address that lack of diversity, Medable and CVS have forged a collaboration to improve patient access to clinical trial research.

  February 7, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Sanofi Scores FDA Nod for Rare Anemia Drug

  The FDA’s decision is based on favorable results from Sanofi’s Phase III CARDINAL trial, a 26-week open label, single arm study on 24 CAD patients.

  February 7, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Genetown

  More Severe, Virulent HIV Variant Discovered in the Netherlands

  Revealed in an article published in Science magazine, this new variant of HIV was discovered in individuals in the Netherlands, Belgium and Switzerland.

  February 7, 2022

   · 

  2 min read

   · 

  Hannah Chudleigh
• 

  Business

  Swiss Rival CEOs Take Home More than $12M Each in 2021

  Novartis CEO Vas Narasimhan and Roche CEO Severin Schwan saw revenue growth for the past year, and each took home more than $12 million in total compensation for 2021.

  February 7, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Biopharma, COVID-19 Response Drove Thermo Fisher’s 2021 Revenue Bump

  Business with customers in the pharma and biotech sector was a key revenue driver, said Thermo Fisher CEO Marc Casper, adding that this business grew by 25% over the year.

  February 7, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Drug Development

  FDA Investigating Possible Death Risk Linked to TG Therapeutics’ Lymphoma Drug

  The U.S. Food and Drug Administration announced they are investigating a possible death risk for TG Therapeutics’ Ukoniq (umbralisib).

  February 7, 2022

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Report Alleges Bullying by Top White House Scientific Advisor

  According to Politico, an internal White House investigation confirmed the alleged abuses from Lander, the president and founding director of the Broad Institute.

  February 7, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Cancer and Fibrosis Innovator Nets $101M to Advance Precision Medicines

  San Diego-based Endeavor BioMedicines closed on a Series B financing worth $101 million.

  February 7, 2022

   · 

  2 min read

   · 

  Mark Terry